SCHEDULE: BlackRock Boosts MicroVision Stake to 5.8% in 13G Filing

Sentiment:

Beneficial Ownership Disclosure


BlackRock, Inc. has disclosed a 5.8% beneficial ownership in MicroVision, Inc., holding 17,358,107 common shares, according to its amended Schedule 13G.

Summary

  • BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G regarding its beneficial ownership in MicroVision, Inc.
  • The filing reports BlackRock, Inc.'s aggregate beneficial ownership of 17,358,107 shares of MicroVision, Inc. Common Stock.
  • This ownership represents 5.8% of the class of securities outstanding.
  • BlackRock, Inc. holds sole voting power over 17,052,052 shares.
  • BlackRock, Inc. holds sole dispositive power over 17,358,107 shares.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of MicroVision, Inc.
  • Several BlackRock subsidiaries are identified as entities that may beneficially own 5% or greater of the outstanding shares, including BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRock Fund Advisors, BlackRock Asset Management Ireland Limited, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership by an institutional investor and does not contain information that inherently indicates a positive or negative sentiment regarding the issuer's performance or prospects. The sentiment is neutral as it is a standard regulatory update.

Positives

  • Increased institutional ownership by a major asset manager like BlackRock can signal confidence in MicroVision, Inc.'s long-term prospects.
  • The acquisition of shares was stated to be in the ordinary course of business, indicating a standard investment rather than an activist stance.

Risks

  • The filing itself does not detail specific risks related to MicroVision, Inc.'s operations or financial health; it is a disclosure of ownership.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding MicroVision, Inc.'s future performance or BlackRock's investment strategy beyond the current ownership disclosure.

Industry Context

BlackRock, as one of the world's largest asset managers, frequently takes significant positions in publicly traded companies. Its 5.8% stake in MicroVision, a company focused on lidar and display technologies, reflects ongoing institutional interest in the advanced technology and automotive sensor sectors. Such an investment by a prominent firm can often be interpreted by the market as a validation of the company's potential.

Stakeholder Impact

  • Shareholders: May view BlackRock's significant stake as a positive signal of institutional confidence and potential long-term stability.
  • Investors: Provides transparency regarding a major institutional investor's position in MicroVision, which can influence investment decisions.

Key Dates

DateDescription
04/30/2023Date of previously revoked Power of Attorney for BlackRock, Inc.
01/21/2025Effective date of the new Power of Attorney for BlackRock, Inc. signatories.
09/30/2025Date of event which required the filing of this Schedule 13G statement, indicating the ownership threshold was met or exceeded.
10/17/2025Signature date of the Schedule 13G filing by BlackRock, Inc.

Keywords

MicroVision, BlackRock, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, MVIS

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.